Progressing Spatial Biology & Digital Pathology into the Clinic to Achieve Unique Insights & Meaningful Clinical Outcomes

• Validating novel technologies and demonstrating their value as tools for clinical progression
• Navigating the regulatory landscape of bringing spatial omics & digital pathology into clinical studies
• Clinical data to highlight the unique benefit of employing spatial biology and digital pathology for patient selection, biomarker validation and toxicity testing

Speakers:

Dorothy French

Executive Director - Translational Pathology

Amgen